RxDoctor Payments Data

Andrea Bruce, DO

Family Medicine · Collins, MSNPI 1295739894

Payments from drug & device makers

$295in general payments, 2019–2025

Across 18 payments — averaging $16.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$74
  • Novo Nordisk$38
  • GSK$36
  • Pfizer$27
  • IBSA Pharma Inc.$23
  • Novartis$21
  • plus $77 from 5 others

What the payments were for

  • Food & beverage$295100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$295 in reported general payments places this provider in the 35th percentile of 971 family medicine providers in Mississippi.

See all family medicine providers in Mississippi

Medicare billing

Part B allowed, 2024
$20,133
Medicare patients
86
Services billed
451

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab15$101,763
EliquisApixaban62$39,416
OzempicSemaglutide22$36,975
JardianceEmpagliflozin25$30,304
JanumetSitagliptin Phos/Metformin Hcl24$23,834
Trelegy ElliptaFluticasone/Umeclidin/Vilanter25$21,966
LinzessLinaclotide33$19,825
JentaduetoLinagliptin/Metformin Hcl25$15,969
FarxigaDapagliflozin Propanediol19$14,797
TradjentaLinagliptin28$14,653
MounjaroTirzepatide14$14,511
EntrestoSacubitril/Valsartan16$11,737
Lantus SolostarInsulin Glargine,hum.Rec.Anlog65$10,681
Breo ElliptaFluticasone/Vilanterol16$9,842
Tresiba Flextouch U-100Insulin Degludec12$7,669

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Jentadueto, Tradjenta$20$60,92778 claims
PfizerEliquis$27$39,41662 claims
Novo NordiskOzempic$38$36,97522 claims
GSKTrelegy Ellipta, Breo Ellipta$36$31,80841 claims
MerckJanumet$14$23,83424 claims
AbbVieLinzess$74$19,82533 claims
AstraZenecaFarxiga$12$14,79719 claims
NovartisEntresto$21$11,73716 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 971 family medicine providers in Mississippi.

Other family medicine in Collins

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →